Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
- F. van Hunsel, A. Passier, K. van Grootheest
- Medicine, Political ScienceBritish Journal of Clinical Pharmacology
- 1 May 2009
Patient reports can provide additional information, making them a useful source of information next to health professional reports, and patients' concerns about adverse reactions should be recognized in reports to national pharmacovigilance centres.
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study
- F. van Hunsel, A. Talsma, E. V. van Puijenbroek, L. de Jong-van den Berg, K. van Grootheest
- MedicinePharmacoepidemiology and Drug Safety
- 1 March 2011
To determine the contribution of patients' adverse drug reaction (ADR) reports to signals detection, through a study of the signals sent by Lareb to the Dutch Medicines Evaluation Board.
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
- F. van Hunsel, Christine Cramer- van der Welle, A. Passier, E. V. van Puijenbroek, K. van Grootheest
- Medicine, PsychologyEuropean Journal of Clinical Pharmacology
- 24 July 2010
The high level of response to the questionnaire shows that patients are involved when it comes to ADRs and that they are also willing to share their motivations for and opinions about the reporting of ADRs with a pharmacovigilance centre.
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
- L. Härmark, F. van Hunsel, E. Hak, K. van Grootheest
- MedicineVaccine
- 24 February 2011
Adverse drug reactions of montelukast in children and adults
- M. Haarman, F. van Hunsel, T. D. de Vries
- Medicine, PsychologyPharmacology Research & Perspectives
- 20 September 2017
It is demonstrated that montelukast is associated with neuropsychiatric adverse drug reactions such as depression and aggression, especially in children nightmares are reported frequently, and the causal relationship has not been established.
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
- Sarah Watson, R. Chandler, F. van Hunsel
- Medicine, PsychologyDrug Safety
- 20 September 2017
Novel approaches to highlighting patient reports in statistical signal detection can further improve the contribution of patient reports to pharmacovigilance and identify safety concerns described in patient reports within the World Health Organization programme for international drug monitoring.
What Motivates Patients to Report an Adverse Drug Reaction?
- F. van Hunsel, Elaine A A M ten Berge, S. Borgsteede, K. van Grootheest
- BiologyThe Annals of Pharmacotherapy
- 1 May 2010
Adverse food-drug interactions.
- A. de Boer, F. van Hunsel, A. Bast
- MedicineRegulatory toxicology and pharmacology : RTP
- 1 December 2015
The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
- L. Rolfes, F. van Hunsel, K. Taxis, E. V. van Puijenbroek
- Medicine, PsychologyDrug Safety
- 4 May 2016
Patients who reported possible ADRs after the Thyrax® packaging change experienced a significant decrease in HR-QOL, highest for the domains ‘daily activities’, ‘overall health status’; and ‘mental health’ and lowest for ‘physical fitness’.
Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
- L. Davidson, J. M. Van den Reek, B. Kullberg
- Medicine, BiologyThe Lancet Regional Health - Europe
- 1 November 2021
...
...